Drug profile · INN
trihexyphenidyl hydrochloride
TRIHEXYPHENIDYL HYDROCHLORIDE
trihexyphenidyl hydrochloride (TRIHEXYPHENIDYL HYDROCHLORIDE) is a muscarinic acetylcholine receptor m1 antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — trihexyphenidyl hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
trihexyphenidyl hydrochloride (TRIHEXYPHENIDYL HYDROCHLORIDE) is a muscarinic acetylcholine receptor m1 antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M1 antagonist
Primary target: Muscarinic acetylcholine receptor M1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is trihexyphenidyl hydrochloride?
trihexyphenidyl hydrochloride (TRIHEXYPHENIDYL HYDROCHLORIDE) is a muscarinic acetylcholine receptor m1 antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trihexyphenidyl hydrochloride?
TRIHEXYPHENIDYL HYDROCHLORIDE is a marketed brand name for trihexyphenidyl hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trihexyphenidyl hydrochloride?
trihexyphenidyl hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.